L-tyrosine: stress, fatigue, and the limits of amino-acid supplementation

L-tyrosine is a non-essential amino acid that serves as the precursor for the catecholamines dopamine, noradrenaline, and adrenaline. The supplement-aisle logic: take more precursor, make more catecholamine, improve stress tolerance and cognition. The trial evidence supports this in specific contexts but is much thinner than the marketing implies.

What the trials show#

The clearest evidence is in acute stress challenges:

• Cold stress: military and lab trials show preserved cognitive performance under acute cold exposure with tyrosine pretreatment (Banderet & Lieberman 1989 and follow-ups)
• Sleep deprivation: modest preservation of cognitive performance after sleep loss in some trials
• Altitude: small trials suggest reduced cognitive decline at altitude
• Multitasking under stress — trials in military and emergency-services populations show improved performance vs placebo

Effect sizes are modest and the trials are typically small.

The evidence in non-stressed healthy adults is much thinner. Tyrosine doesn't appear to enhance cognition in well-rested, well-fed conditions in trial data.

The mechanism story#

Under high catecholamine demand (acute stress, sleep deprivation, cold), brain catecholamine synthesis may become substrate-limited. Supplemental tyrosine in this context provides additional precursor and may preserve catecholaminergic signalling.

Under normal conditions, dietary tyrosine and phenylalanine intake is more than adequate; supplemental tyrosine doesn't increase brain catecholamine synthesis meaningfully.

This explains the specific-context evidence pattern; tyrosine helps where catecholamine demand exceeds normal substrate supply.

What gets overstated#

• "Boosts dopamine and motivation." No. Supplemental tyrosine doesn't meaningfully raise baseline dopamine in healthy adults.
• "Treats depression." Trial evidence is sparse and negative for major depression. Some small trials in mild depression have been positive but the evidence is not at first-line treatment level.
• "Replaces stimulants for focus." Tyrosine has modest effects compared to caffeine or prescription stimulants.

Dose and timing#

Trial doses range from 100 mg/kg (about 7–10 g for a typical adult) for acute pre-stress dosing, down to 1–2 g daily for chronic use. The acute-stress trials use higher doses; chronic-use trials use lower.

Most consumer products dose at 500–1,000 mg, taken once or twice daily.

Timing matters more than for some supplements: for acute stress protocols, 30–60 minutes before the stress is what the trials use.

Side effects#

L-tyrosine is generally well-tolerated:

• GI symptoms at higher doses
• Headache in some users
• Anxiety / jitteriness if you're naturally tightly-wound (the catecholamine pathway is what it acts on)

Interactions#

• MAOIs: significant interaction; can cause hypertensive crisis. Don't combine.
• Levothyroxine: tyrosine is a thyroid hormone precursor; theoretical interaction; separate timing from medication
• Stimulants (caffeine, ADHD medication): additive sympathetic activation; some users find this useful, some find it uncomfortable
• L-DOPA / Parkinson's medications — theoretical competitive absorption; clinical relevance unclear

UK regulatory framing#

Sold as a food supplement; not regulated as a medicine. Generally available; no specific MHRA restrictions.

What we'd actually say#

For acute stress contexts (a high-pressure presentation, sleep-deprivation work, cold exposure, altitude) there's reasonable trial evidence for a single dose 30–60 minutes beforehand. This is the use case where tyrosine has real evidence.

For chronic daily use seeking general "dopamine" benefits, the evidence is thin and the likely effect modest at best.

For depression, ADHD, or similar clinical conditions, tyrosine is not a substitute for evidence-based treatment. See your GP.

When to talk to a clinician#

• On MAOIs: do not combine with tyrosine
• Hyperthyroidism: discuss before starting
• Phenylketonuria (PKU): special consideration
• On levothyroxine or Parkinson's medications
• Cardiovascular conditions where catecholamine activation is concerning
• Any unexpected reaction: Yellow Card reportable